Salix Pharmaceuticals

Allergan Fined $15M Over Disclosure Failures
Risk & Compliance

Allergan Fined $15M Over Disclosure Failures

The SEC says the drug maker failed to timely inform investors about its merger talks with Salix and Actavis.
By Matthew Heller | January 18, 2017
Read More
Salix CFO Resigns as Board Reviews Inventory Accounting
Supply Chain

Salix CFO Resigns as Board Reviews Inventory Accounting

Are high levels of inventory at wholesalers indicative of improper accounting of sales?
By Matthew Heller | November 10, 2014
Read More
Salix Calls Off Tax Inversion Deal
Tax

Salix Calls Off Tax Inversion Deal

The Treasury Department's recent anti-inversion measures claim their first victim — Salix Pharmaceuticals' plan to merge with Italy-based Cosmo.
By Iris Dorbian | October 3, 2014
Read More
Another Tax Inversion Deal in the Works
Tax

Another Tax Inversion Deal in the Works

The hue and cry over tax inversions is not stopping companies from proceeding with more mergers that take advantage of the tactic.
By Iris Dorbian | July 28, 2014
Read More